Arixtra® (fondaparinux sodium), is a pentasaccharide derived from the portion of heparin that binds to antithrombin and inhibits
FXa.
Arixtra® is obtained by chemical synthesis, while anticoagulants of the heparin family are of animal origin.
It is used as a preventive measure for venous thromboembolic events or used as a treatment for venous thrombosis.
TECHNOVIEW® Arixtra® Cal Set and Cont Low and High plasmas are prepared from citrated plasmas supplemented with different concentrations of Arixtra® (fondaparinux sodium).
They allow validation of the calibration curve for Arixtra® assays in plasma, in particular with anti-FXa assay methods.
The calibration curve encompasses the current concentrations obtained during treatment with Arixtra®.
- 6 vials x 1 mL lyophilized plasma
